As expected, James Sweeney last week was named chairman of newly formed home infusion company Coram Healthcare Corp., filling the final management hole in what soon will be the nation's second largest home infusion provider.
Earlier this month, MODERN HEALTHCARE reported that Mr. Sweeney was a leading candidate for the position at Coram, which was formed through the $550 million merger of T2 Medical, Curaflex Health Services, HealthInfusion and Medisys (Feb. 14, p. 32). He most recently was chairman of hospital supplier McGaw.
Mr. Sweeney's name is quite familiar to home infusion providers. He founded Caremark in 1979 and operated it as one of the most successful home infusion companies in the nation until selling it to Baxter International in 1987 for $586 million.
Most recently, he served on the board of directors at Medical Care America. He resigned from his position in December, shortly before Medical Care sold its struggling home infusion line-Critical Care America-to Caremark International for $175 million.
Mr. Sweeney joins a management team that will include Curaflex's Charles Laverty, recently named president and CEO of Coram, and T2 co-founder Tommy Carter, who was named vice chairman of the company.